Take a look at how we solved the delivery problem and introduced a completely new treatment option for cold sores.

Let’s talk about cold sores

Seriously—LET’S TALK ABOUT COLD SORES!!!

They’re painful. They’re visible and embarrassing. They interrupt your life, your work, your confidence. And if you’re one of the 3.8 billion people around the world who carry herpes simplex virus-1 (HSV-1), you know how frustrating they can be.

What’s even more frustrating?

The total lack of innovation in cold sore therapy.

• Topical acyclovir was FDA-approved in 1982.

• Docosanol (Abreva) came in 2000—does purified behenyl alcohol (that’s what docosanol is) really do anything?

• Oral antivirals like valacyclovir and famciclovir require perfect timing and systemic dosing, and they don’t prevent barrier damage or reduce inflammation.

And natural remedies?

• Propolis is wildly inconsistent, batch-dependent, and often no more effective than placebo.

• Lysine is mostly used preventatively and doesn’t reliably impact active outbreaks. Lysine will not penetrate the skin and does not work in topical formulations.

• Over the counter gels and sticks? They just numb the pain or create a temporary shield.

The truth is, cold sore care has been stuck in the same loop for over 40 years.

We’ve known for years that flavonoids possess potent antiviral properties, our research made that clear. But when our customers began asking for something cleaner, faster, and plant-based, we moved quickly to translate that science into a real-world solution. Continue Reading